Revance Therapeutics Inc (NASDAQ:RVNC) traded at $3.40 at close of the session on Friday, April 26, made an upward move of 3.34% on its previous day’s price.
Looking at the stock we see that its previous close was $3.29 . In terms of its 52-week price range, RVNC has a high of $37.98 and a low of $3.23. The company’s stock has lost about -31.17% over that past 30 days.
Revance Therapeutics Inc has a market cap of $354.35 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.75, with the EPS growth for the year raised at -$2.3 for 2024 and -$1.06 for next year. These figures represent 39.90% and 53.90% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $56.63 million, with a low of $53.47 million and a high of $59.6 million. The median projection represents growth squeezing down to 14.80% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $281.72 million, or 20.40% up from figures reported last year.
On the other hand, looking at the outlook for the RVNC stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -17.99% off its SMA20 and -32.58% from its 50-day simple moving average. The RSI (14) is pointing at 27.78 while the volatility over the past week is 7.53% and jumps to 6.26% over the past one month. The beta value is 1.17, while the average true range (ATR) is currently pointing at 0.30.
Coming back to Revance Therapeutics Inc (NASDAQ:RVNC), we note that the average 3-month trading volume was 1.81 million. Current shares outstanding are 104.22 million.
The insiders hold 8.63% of the company’s shares while institutions hold 75.24%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -61.32% down in year-to-date price movement.
